Screener

R&D

Name: Agios Pharmaceuticals R&D by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Agios Pharmaceuticals·Business Segments·1 segment·Rolls up to R&D

Breakdown

Segment	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26	Q2 '26
Business Segments	-$21.32M	$29.81M	$30.53M	-$189.75M	$23.91M	$25.85M
Total	$72.74M	$91.94M	$86.8M	$88.06M	$81.15M	$100.75M

Business SegmentsView metric